123 related articles for article (PubMed ID: 36047204)
1. TARC/CCL17 Expression Is Associated with CD8
Gao Y; Kuwahara S; Kazaoka A; Ito K; Aoki S
Biol Pharm Bull; 2022; 45(9):1347-1353. PubMed ID: 36047204
[TBL] [Abstract][Full Text] [Related]
2. IFN-gamma-inducible expression of thymus and activation-regulated chemokine/CCL17 and macrophage-derived chemokine/CCL22 in epidermal keratinocytes and their roles in atopic dermatitis.
Horikawa T; Nakayama T; Hikita I; Yamada H; Fujisawa R; Bito T; Harada S; Fukunaga A; Chantry D; Gray PW; Morita A; Suzuki R; Tezuka T; Ichihashi M; Yoshie O
Int Immunol; 2002 Jul; 14(7):767-73. PubMed ID: 12096036
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the immune tolerance system determines the susceptibility to HLA-mediated abacavir-induced skin toxicity.
Susukida T; Kuwahara S; Song B; Kazaoka A; Aoki S; Ito K
Commun Biol; 2021 Sep; 4(1):1137. PubMed ID: 34584206
[TBL] [Abstract][Full Text] [Related]
4. Thymus- and activation-regulated chemokine (TARC/CCL17) induces a Th2-dominated inflammatory reaction on intradermal injection in mice.
Vestergaard C; Deleuran M; Gesser B; Larsen CG
Exp Dermatol; 2004 Apr; 13(4):265-71. PubMed ID: 15086343
[TBL] [Abstract][Full Text] [Related]
5. The PD1 inhibitory pathway and mature dendritic cells contribute to abacavir hypersensitivity in human leukocyte antigen transgenic PD1 knockout mice.
Song B; Aoki S; Liu C; Susukida T; Kuwahara S; Ito K
Toxicology; 2021 Nov; 463():152971. PubMed ID: 34606953
[TBL] [Abstract][Full Text] [Related]
6. A transgenic mouse model for HLA-B*57:01-linked abacavir drug tolerance and reactivity.
Cardone M; Garcia K; Tilahun ME; Boyd LF; Gebreyohannes S; Yano M; Roderiquez G; Akue AD; Juengst L; Mattson E; Ananthula S; Natarajan K; Puig M; Margulies DH; Norcross MA
J Clin Invest; 2018 Jul; 128(7):2819-2832. PubMed ID: 29782330
[TBL] [Abstract][Full Text] [Related]
7. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity.
Kakinuma T; Nakamura K; Wakugawa M; Mitsui H; Tada Y; Saeki H; Torii H; Asahina A; Onai N; Matsushima K; Tamaki K
J Allergy Clin Immunol; 2001 Mar; 107(3):535-41. PubMed ID: 11240957
[TBL] [Abstract][Full Text] [Related]
8. Conjugation of human serum albumin and flucloxacillin provokes specific immune response in HLA-B*57:01 transgenic mice.
Gao Y; Song B; Aoki S; Ito K
Immunol Lett; 2022 Sep; 249():5-11. PubMed ID: 35963284
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of immune-mediated idiosyncratic drug toxicity using chimeric HLA transgenic mice.
Susukida T; Aoki S; Kogo K; Fujimori S; Song B; Liu C; Sekine S; Ito K
Arch Toxicol; 2018 Mar; 92(3):1177-1188. PubMed ID: 29150704
[TBL] [Abstract][Full Text] [Related]
10. Role of the chemokine receptor CCR4 and its ligand thymus- and activation-regulated chemokine/CCL17 for lymphocyte recruitment in cutaneous lupus erythematosus.
Wenzel J; Henze S; Wörenkämper E; Basner-Tschakarjan E; Sokolowska-Wojdylo M; Steitz J; Bieber T; Tüting T
J Invest Dermatol; 2005 Jun; 124(6):1241-8. PubMed ID: 15955100
[TBL] [Abstract][Full Text] [Related]
11. Transgenic murine models for the study of drug hypersensitivity reactions linked to HLA-I molecules.
Puig M; Norcross MA
Curr Opin Allergy Clin Immunol; 2023 Aug; 23(4):279-286. PubMed ID: 37284777
[TBL] [Abstract][Full Text] [Related]
12. Development of mouse models with restricted HLA-B∗57:01 presentation for the study of flucloxacillin-driven T-cell activation and tolerance in liver injury.
Ananthula S; Krishnaveni Sivakumar K; Cardone M; Su S; Roderiquez G; Abuzeineh H; Kleiner DE; Norcross MA; Puig M
J Allergy Clin Immunol; 2023 Aug; 152(2):486-499.e7. PubMed ID: 37030592
[TBL] [Abstract][Full Text] [Related]
13. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin.
Vestergaard C; Bang K; Gesser B; Yoneyama H; Matsushima K; Larsen CG
J Invest Dermatol; 2000 Oct; 115(4):640-6. PubMed ID: 10998136
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of 5,6-dihydroergosteol-glucoside on atopic dermatitis-like skin lesions via suppression of NF-κB and STAT activation.
Jung M; Lee TH; Oh HJ; Kim H; Son Y; Lee EH; Kim J
J Dermatol Sci; 2015 Sep; 79(3):252-61. PubMed ID: 26100037
[TBL] [Abstract][Full Text] [Related]
15. Allopurinol suppresses expression of the regulatory T-cell migration factors TARC/CCL17 and MDC/CCL22 in HaCaT keratinocytes via restriction of nuclear factor-κB activation.
Osabe M; Tajika T; Tohkin M
J Appl Toxicol; 2018 Feb; 38(2):274-283. PubMed ID: 28949055
[TBL] [Abstract][Full Text] [Related]
16. Chemokine expression in diverse nonimmediate drug hypersensitivity reactions: focus on thymus activation-regulated chemokine, cutaneous T-cell-attracting chemokine, and interleukin-10.
Wang F; He D; Tang X; Zhang X
Ann Allergy Asthma Immunol; 2014 Aug; 113(2):204-8. PubMed ID: 24932689
[TBL] [Abstract][Full Text] [Related]
17. Cultivated ginseng inhibits 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice and TNF-α/IFN-γ-induced TARC activation in HaCaT cells.
Choi JH; Jin SW; Park BH; Kim HG; Khanal T; Han HJ; Hwang YP; Choi JM; Chung YC; Hwang SK; Jeong TC; Jeong HG
Food Chem Toxicol; 2013 Jun; 56():195-203. PubMed ID: 23454147
[TBL] [Abstract][Full Text] [Related]
18. Enhanced TARC production by dust-mite allergens and its modulation by immunosuppressive drugs in PBMCs from patients with atopic dermatitis.
Furukawa H; Nakamura K; Zheng X; Tojo M; Oyama N; Akiba H; Nishibu A; Kaneko F; Tsunemi Y; Saeki H; Tamaki K
J Dermatol Sci; 2004 Jun; 35(1):35-42. PubMed ID: 15194145
[TBL] [Abstract][Full Text] [Related]
19. Determination of thymus and activation-regulated chemokine (TARC)-contents in scales of atopic dermatitis.
Morita E; Hiragun T; Mihara S; Kaneko S; Matsuo H; Zhang Y; Dekio S
J Dermatol Sci; 2004 May; 34(3):237-40. PubMed ID: 15113595
[TBL] [Abstract][Full Text] [Related]
20. Expression of thymus and activation-regulated chemokine (TARC) by human dermal cells, but not epidermal keratinocytes.
Shoda T; Futamura K; Kobayashi F; Saito H; Matsumoto K; Matsuda A
J Dermatol Sci; 2014 Nov; 76(2):90-5. PubMed ID: 25219597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
